Johnson & Johnson CFO Joseph Wolk sits down with CNBC’s Meg Tirrell and the ‘Squawk Box’ team to react to the company’s latest fourth-quarter earnings report. Wolk explains why the pharma giant expects a stronger second half of 2022 compared to the first and discusses the company’s M&A outlook. Wolk also lays out J&J’s plans for splitting into two separate companies.